Furthermore, as the upstream regulatory element, KIF23 could also damage the activation of the tumor repressive p53 pathway, accompanied by the reductive levels of p21 as well as the enhancement of HCC cells motility and viability in vitro [85]. The gene discussed is TP53; the disease is hepatocellular carcinoma.